To receive daily emails from Breaking Christian News to your inbox CLICK HERE


SHARE THIS ARTICLE Printer friendly version of this page

Israel Starts Clinical Trial of Antibody COVID Vaccine: 3 Patients Already Able to Leave Hospital

Abigail Klein Leichman : Aug 13, 2020  ISRAEL21c.org

"We are encouraged by the results of the product neutralization activity and we believe our product has the potential to be an effective treatment for hospitalized, non-ventilated COVID-19 patients with pneumonia, and look forward to the results from this trial." -Amir London, Kamada's CEO

[ISRAEL21c.org] Physicians at Hadassah University Medical Center in Jerusalem report promising early results of a clinical study in which they are treating Covid-19 patients with immunoglobulin (IgG) derived from the plasma of recovered patients found to have high levels of antibodies. (Screengrab image: via Kamada)

The serum is prepared by Rehovot-based biopharmaceutical company Kamada.

Three patients have already received the serum and are doing well, according to Dr. Yaron Ilan, chief of internal medicine at Hadassah University Medical Center. "The first patient demonstrated a rapid clinical benefit and went home after previously being in moderate condition."

The other two also have been released from the hospital.

Ilan stressed that this experimental treatment, though very encouraging, is in an early phase.

Dr. Zeev Rotstein, director general of Hadassah Medical Center, called their recovery "almost a miracle."

Rotstein was among the initiators of the collection of plasma from recovered corona patients. He also revealed to the Jerusalem Post on August 12 that Hadassah will help test a Russian-developed vaccine for coronavirus.

For the past three months, Hadassah has been collecting plasma donations from recovered patients with the cooperation of ultra-Orthodox communal organizations.

Kamada said additional Israeli hospitals are taking part in this Phase 1/2 clinical trial of the anti-SARS-CoV-2 plasma-derived IgG.

"This open-label, single-arm multicenter study was approved by the Ministry of Health in Israel. The trial will assess the safety, pharmacokinetics and pharmacodynamics of the company's plasma-derived IgG product in hospitalized, non-ventilated Covid-19 patients with pneumonia," Kamada reported.

"A total of 12 eligible patients will be enrolled and receive Kamada's product at a single dose of 4g within 10 days of initial symptoms. Patients will be followed for 84 days. In parallel, Kamada intends to further explore the potential of its IgG product to prevent Covid-19 disease in healthy subjects at risk in a separate study."

This milestone is part of the global collaboration agreement established in April 2020 between Kamada and its partner Kedrion Biopharma for the development, manufacturing and distribution of a plasma-derived immunoglobulin product as a potential treatment for coronavirus disease.

Kamada and Kedrion intend to conduct a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration soon in anticipation of obtaining FDA approval of the proposed clinical development program. Meanwhile, Kedrion will collect Covid-19 convalescent plasma from recovered American patients.

"We are encouraged by the results of the product neutralization activity and we believe our product has the potential to be an effective treatment for hospitalized, non-ventilated COVID-19 patients with pneumonia, and look forward to the results from this trial," said Amir London, Kamada's CEO. Subscribe for free to Breaking Christian News here







SHARE THIS ARTICLE Printer friendly version of this page

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Other Recent Articles from Breaking Christian News

Outrage: Idaho Police Arrest Three Christians Singing Hymns during Outdoor Worship Service without Masks

President Trump to Push for Juneteenth (Cessation of Slavery) to Become National Holiday: Report

Ohio Mom Tased and Arrested for Not Wearing a Mask at Son's Outdoor Football Game; She's Asthmatic

President Gets Ready to Announce SCOTUS Nominee While Democrats Plan Pressure Campaign

Woman Who Survived Abortion Thanks Trump for Signing 'Born Alive' Executive Order

Millions Around the World Join 'The Return: National Day of Prayer and Repentance'

Franklin Graham Talks to CBN News About Saturday's Prayer March, the Election and the Supreme Court Battle

Vietnamese Pastor Released from Prison: 'He Should Never Have Been Imprisoned in the First Place'

Trump Signing 'Born Alive' Executive Order Protecting Babies that Survive Botched Abortions

3,000 Pro-lifers Take Part in German March for Life amid Covid Restrictions

Truth Comes Out: Grand Jury's Breonna Taylor Decision Reveals It Was Not a 'No-Knock' Warrant

Dr. Alveda King: African-Americans Supporting Trump because of His 'Stand for Life'

President Trump's Executive Order on Combating Race and Sex Stereotyping in Federal Workforce

Senate Report Links Hunter Biden to Human Trafficking Ring, and Joe Biden WAS Briefed on His Son's Burisma Involvement

China's Communist Regime Changes Bible Story; Says Jesus Killed Woman Caught in Adultery: 'I, Too, Am a Sinner'

American Sign Language Bible Translation Completed after 39 Years

'This Is Not Political, This Is Simply Biblical!': Thousands Hit the Streets in FL Where Souls Were 'Running to Get Saved'

A Kenosha Church's Miracle in the Midst of Chaos: 'God Gave It to Us to Be a Beacon Where Light Is Dim'

Secretary of State Mike Pompeo Encourages Christians to Keep Faith in the Public Square

Numbers Don't Lie: Trump's Economy Produced the Lowest Poverty Rate on Record in US before Covid



Search the Articles Archives

Keyword:  
Author:  
Words Posted On:  
Day Month Year



BCN Plus

An BCN Paid Advertisement
An BCN Paid Advertisement
Follow BCN on Twitter
Are You Praying for Our Government Leaders?
BCN Staff

Steve Shultz
Steve Shultz, Managing Editor
Founder and Owner


Aimee Herd
Aimee Herd, Editor


BCN Plus
Are You Praying for President Trump?
 
 
BCN Contact Info

All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2019. All Rights Reserved.


Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved


Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.

editor@breakingchristiannews.com